STE
STERIS plc
NYSE: STE · HEALTHCARE · MEDICAL DEVICES
$212.65
-3.23% today
Updated 2026-04-29
Market cap
$20.87B
P/E ratio
29.66
P/S ratio
3.58x
EPS (TTM)
$7.17
Dividend yield
1.09%
52W range
$210 – $269
Volume
0.8M
WallStSmart proprietary scores
60
out of 100
Grade: C+
Hold
Investment rating
6.0
Growth
B7.3
Quality
B+6.5
Profitability
B4.0
Valuation
C6/9
Piotroski F-Score
Moderate
2.4
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$279.29
+31.34%
12-Month target
$215.36
+1.27%
Intrinsic (DCF)
$193.71
Margin of safety
-25.69%
2 Strong Buy3 Buy2 Hold0 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $199.50M — positive
Risks
- 25.69% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $4.22B | $4.54B | $5.14B | $5.46B | $5.83B | $6.0B |
| Net income | $243.89M | $107.03M | $378.24M | $614.64M | $192.80M | — |
| EPS | — | — | — | — | $7.17 | $10.30 |
| Free cash flow | $397.25M | $394.98M | $612.95M | $778.00M | $199.50M | — |
| Profit margin | 5.77% | 2.36% | 7.36% | 11.26% | 12.10% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-05 | FELDMANN, CYNTHIA L | Buy | 3,098 | $152.32 |
| 2026-03-05 | FELDMANN, CYNTHIA L | Sale | 3,098 | — |
| 2026-01-02 | MCGOWAN, LINDSEY | Buy | 798 | — |
Peer comparison
Smart narrative
STERIS plc trades at $212.65. representing a P/E of 29.66x trailing earnings. Our Smart Value Score of 60/100 indicates the stock is good. The company scores 6/9 on the Piotroski F-Score. With an Altman Z-Score of 2.41, it sits in the grey zone. TTM revenue stands at $5.83B. with profit margins at 12.10%. Our DCF model estimates intrinsic value at $193.71.
Frequently asked questions
What is STERIS plc's stock price?
STERIS plc (STE) trades at $212.65.
Is STERIS plc overvalued?
Smart Value Score 60/100 (Grade C+, Hold). DCF value $193.71.
What is the price target of STERIS plc (STE)?
The analyst target price is $279.29, representing +31.3% upside from the current price of $212.65.
What is the intrinsic value of STERIS plc (STE)?
Based on our DCF model, intrinsic value is $193.71, a -25.7% margin of safety versus $212.65.
What is the future stock price of STE by 2030?
Our research-backed model estimates STERIS plc could reach $967.87 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is STERIS plc's revenue?
TTM revenue is $5.83B.
Piotroski F-Score?
6/9 — moderate financial health.
Altman Z-Score?
2.41 — grey zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio3.58x
ROE10.50%
Beta1.07
50D MA$227.67
200D MA$243.24
Shares out0.10B
Float0.10B
Short ratio—
Avg volume0.8M
Performance
1 week-4.13%
1 month-3.31%
3 months-19.02%
YTD-16.12%
1 year—
3 years—
5 years—